Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label, Phase 2 Study to Evaluate Safety and Efficacy of U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer (CRC)

NCT04479436 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04479436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label, Phase 2 Study to Evaluate Safety and Efficacy of U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer (CRC)
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Terminated
Start date
September 14, 2020
Completion date
February 3, 2022
Enrollment
40 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer